Histopathologic Features in Animal Model of Atopic Dermatitis Induced by Topical Application of Oxazolone
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Animal models of atopic dermatitis (AD) are widely used to investigate therapeutic effects of candidates for AD. However, the characteristics of each model are not fully understood. This study was designed to compare the animal models of dermatitis induced by dinitrofluorobenzene (DNFB) and oxazolone (Ox). We investigated the effects of DNFB and Ox on skin thicknesses and weights as well as skin lesions associated with AD such as scale, crust and erythematous eruption, and histopathological changes such as hyperkeratosis, dermal and epidermal hyperplasia and immune cell infiltration in inflamed tissues. Multiple application of 0.5% Ox onto the skin increased skin thickness and weight compared to those of DNFB treated mice, as well as those of normal mice. In addition, topical application of DNFB induced marked scale, crust and erythematous eruption, while Ox induced erythematous eruption and mild scale and crust. Histopathological examination revealed that 0.5% Ox induced marked hyperplasia in the dermis and epidermis, large vesicles, spongiotic changes, mild hyperkeratosis and immune cell infiltration in balb/c mice. These data suggest that multiple applications of Ox can induce chronic AD like dermatitis in balb/c mice.
Abstract
Animal models of atopic dermatitis (AD) are widely used to investigate therapeutic effects of candidates for AD. However, the characteristics of each model are not fully understood. This study was designed to compare the animal models of dermatitis induced by dinitrofluorobenzene (DNFB) and oxazolone (Ox). We investigated the effects of DNFB and Ox on skin thicknesses and weights as well as skin lesions associated with AD such as scale, crust and erythematous eruption, and histopathological changes such as hyperkeratosis, dermal and epidermal hyperplasia and immune cell infiltration in inflamed tissues. Multiple application of 0.5% Ox onto the skin increased skin thickness and weight compared to those of DNFB treated mice, as well as those of normal mice. In addition, topical application of DNFB induced marked scale, crust and erythematous eruption, while Ox induced erythematous eruption and mild scale and crust. Histopathological examination revealed that 0.5% Ox induced marked hyperplasia in the dermis and epidermis, large vesicles, spongiotic changes, mild hyperkeratosis and immune cell infiltration in balb/c mice. These data suggest that multiple applications of Ox can induce chronic AD like dermatitis in balb/c mice.
참고문헌 (14)
- Tanaka A, "Recent findings in mouse models for human atopic dermatitis", Exp Anim, 61(2), pp.77~84 (2012)[DOI]
- Jin H, "Animal models of atopic dermatitis", J Invest Dermatol, 129(1), pp.31~40 (2009)[DOI]
- Christensen AD, "Immunological mechanisms of contact hypersensitivity in mice", APMIS, 120(1), pp.1~27 (2012)
- Man MQ, "Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges", J Invest Dermatol, 128(1), pp.79~86 (2008)[DOI]
- Han HY, "Effects of Dictamnus dasycarpus Turcz., root bark on ICAM-1 expression and chemokine productions in vivo and vitro study", J Ethnopharmacol, 159, pp.245~252 (2015)[DOI]
- Saint-Mezard P, "Allergic contact dermatitis", Eur J Dermatol, 14(5), pp.284~295 (2004)
- Dearman RJ, "Characterization of chemical allergens as a function of divergent cytokine secretion profiles induced in mice", Toxicol Appl Pharmacol, 138(2), pp.308~316 (1996)[DOI]
- Sailstad DM, "A murine model for low molecular weight chemicals: differentiation of respiratory sensitizers (TMA) from contact sensitizers (DNFB)", Toxicology, 194(1-2), pp.147~161 (2003)[DOI]
- Puneet Kaur Randhawa, "A Review on Chemical-Induced Inflammatory Bowel Disease Models in Rodents", The Korean Journal of Physiology & Pharmacology, 18(4), pp.279~288 (2014), 대한약리학회
- Nakanishi T, "Mutant interleukin-4", 13 signaling blockade successfully suppresses acute phase inflammation, 2013, pp.305(3), 241~247
- Morioka T, "IL-4", IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis, 2009, pp.160(6), 1172~1179
- Kim M, "Anti-inflammatory effects of Cryptotympana atrata Fabricius slough shed on contact dermatitis induced by dinitrofluorobenzene in mice", Pharmacogn Mag, 10(Suppl 2), pp.S377~S382 (2014)[DOI]
- Koeper LM, "In vitro differentiation of skin sensitizers by cell signaling pathways", Toxicology, 242(1-3), pp.144~152 (2007)[DOI]
- Zheng H, "Oral administration of ginsenoside Rh1 inhibits the development of atopic dermatitis-like skin lesions induced by oxazolone in hairless mice", Int Immunopharmacol, 11(4), pp.511~518 (2011)[DOI]